Lung cancer obstructs the important system of respiration, which can make breathing exceptionally troublesome. Lung cancer is one of the most commonly diagnosed cancers. It arises when deformity occur in either the lungs or the bronchi (the air tubes leading to the lungs). People who smoke regularly are prone to be on high risk for the disease, and studies tell that females who smoke are more prone to have lung cancer than their male partner. But lung cancer can also be developed in individuals who have not smoked at all before. A person affected with lung cancer is operated by a specialist doctor (onco surgeon) by making a cut on one side of the chest to the affected patient (thorax) by a procedure which is called as a thoracotomy.
How Big is the Global Lung Cancer Surgery Market?
The Lung Cancer Surgery Market is expected to be around US$ 40 Billion by 2027 at a CAGR of 6.8% in the given forecast period.
The major driving factors of Lung Cancer Surgery Market are as follows:
• Growing Technological Advancement in lung cancer treatments
• Rising Geriatric Population
• Growing Incidence and Popularity of Lung Cancer
• Early stage detection and intervention Awareness about the disease
The restraining factors of Lung Cancer Surgery Market are as follows:
• Costliest lung cancer surgeries
The Lung Cancer Surgery Market is segmented on the lines of its procedures type, device type and regional. Based on procedures type segmentation it covers thoracotomy, lobectomy, sleeve resection, segmentectomy, pneumonectomy, minimally invasive surgeries. Based on device type segmentation it covers surgical instruments, hand instruments, powered surgical equipment, monitoring and visualizing systems, endosurgical equipment. The Lung Cancer Surgery Marketon geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Lung Cancer Surgery Market and related technologies.
2) Analyses of global market trends, with data from 2019, estimates for 2020 and 2021, and projections of compound annual growth rates (CAGRs) through 2027.
3) Identifications of new market opportunities and targeted promotional plans for Lung Cancer Surgery Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets onLung Cancer Surgery Marketwith the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Intuitive Surgical Inc. (U.S.), Olympus Corporation (Japan), Accuray Inc. (U.S.), AngioDynamics Inc. (U.S.), Teleflex Inc. (U.S.), Ethicon US LLC (U.S.), KARL STORZ GmbH (Germany), Ackermann Instrumente GmbH (Germany), Scanlan International Inc. (U.S.), and Trokamed GmbH (Germany). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Lung Cancer Surgery Market has been segmented as below: (Accordingly)
By Procedure Type Analysis:
By Devices Type Analysis:
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Lung Cancer Surgery Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Lung Cancer Surgery Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study
3 Executive Summary
3.1 Introduction
3.2 Conclusion
4 Premium Insights
4.1 Lung Cancer Surgical Devices Market Overview
4.2 Geographic Analysis: Lung Cancer Surgical Devices Market, By Type
4.3 Lung Cancer Surgical Procedures Market, By Type, 2019-2025
4.4 Lung Cancer Surgical Devices Market, By Region, 2019-2025
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Technological Advancements in Lung Cancer Treatment
5.2.1.2 Increasing Incidence and Prevalence of Lung Cancer
5.2.1.3 Rising Geriatric Population
5.2.1.4 Increasing Number of Awareness Initiatives Aimed at Early Detection of Cancer
5.2.2 Restraints
5.2.2.1 High Cost of Lung Cancer Surgeries
5.2.3 Opportunities
5.2.3.1 Untapped Emerging Markets
5.2.4 Challenges
5.2.4.1 Entry Barriers for New Players
5.2.4.2 Dearth of Oncologists
6 Lung Cancer Surgical Devices Market, By Type
6.1 Introduction
6.2 Surgical Instruments
6.2.1 Hand Instruments
6.2.1.1 Staplers
6.2.1.2 Forceps
6.2.1.3 Retractors
6.2.1.4 RIB Shears
6.2.1.5 Trocars
6.2.1.6 Cutters
6.2.1.7 Clamps
6.2.1.8 Scissors
6.2.1.9 Elevators
6.2.1.10 Other Hand Instruments
6.3 Monitoring and Visualizing Systems
6.3.1 Cameras & Video Support
6.3.2 Endoscopic Trocars With Optical Views
6.3.3 Endosurgical Equipment
7 Lung Cancer Surgical Procedures Market, By Type
7.1 Introduction
7.2 Thoracotomy
7.2.1 Lobectomy
7.2.2 Sleeve Resection
7.2.3 Segmentectomy
7.2.4 Pneumonectomy
7.3 Minimally Invasive Surgeries
8 Lung Cancer Surgery Market, By Region
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.4 Asia
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 RoA
8.5 Rest of the World (RoW)
9 Lung Cancer Surgical Devices Market , Competitive Landscape
9.1 Introduction
9.2 Strategic Overview
9.3 Market Share Analysis
9.4 Competitive Situation and Trends
9.4.1 Agreements, Partnerships, and Collaborations
9.4.2 Product Launches
9.4.3 Expansions
9.4.4 Acquisitions
9.4.5 Other Developments
10 Company Profiles
10.1 Introduction
10.2 Accuray Incorporated
10.3 Angiodynamics Inc.
10.4 Ethicon Us, LLC (Johnson & Johnson)
10.5 Intuitive Surgical Inc.
10.6 Olympus Corporation
10.7 Teleflex Incorporated
10.8 Ackermann Instrumente GmbH
10.9 Karl Storz GmbH
10.10 Scanlan International, Inc.
10.11 Trokamed GmbH
The Lung Cancer Surgery Market has been segmented as below: (Accordingly)
By Procedure Type Analysis:
By Devices Type Analysis:
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
